News / Press
Bioscience, applied to the skin
Who We Are
Board of Directors
Oops, Post Not Found!
Uh Oh. Something is missing. Try double checking things.
Arcutis Announces Enrollment of Last Patient in Phase 2a Clinical Trial of ARQ-151 Cream as a Potential Topical Treatment for Atopic Dermatitis
Arcutis, Inc.’s Development Program for Eczema
Arcutis, Inc. Announces Positive Top Line Results for Phase 2b Clinical Trial Evaluating ARQ-151 as a Potential Topical Treatment for Plaque Psoriasis
Scott Burrows Joins Arcutis as VP, Finance
ARQ-151 Atopic Dermatitis P2a Trial Initiated